About the Program
Target Audience
This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.
Learning Objectives
After completing this activity, participants should be better able to:
- Describe the options available for initiating ARV therapy in people with HIV infection
- Discuss the data that support the initiation of ARV therapy in various patient populations and circumstances
- Identify barriers to successful ARV therapy, such as side effects
- Use approaches for switching ARV therapy in people with HIV that maintain viral suppression and reduce barriers to good treatment outcomes
- Describe the role of the pharmacist in providing optimal HIV care and in switching ARV therapy
Release Date: April 7, 2022
Expiration Date: April 7, 2023
Media: Internet
Estimated time to complete each Module: 30 minutes
Faculty
Richard A. Elion, MD
Associate Professor of Clinical Medicine
George Washington University Medical Center
Washington, DC
|
Helena Kwakwa, MD
Director HIV Clinical Services
Philadelphia Department of Public Health
Ambulatory Health Services
Philadelphia, Pennsylvania |
Joseph Eron, MD
Professor of Medicine, School of Medicine
Chief, Division of Infectious Diseases
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina |
David E. Koren, PharmD
Adjunct Clinical Assistant Professor
Department of Pharmacy Practice - Temple University School of Pharmacy
Adjunct Assistant Professor
Department of Medicine - Lewis Katz School of Medicine
Clinical Pharmacist Specialist
Infectious Diseases/HIV - Temple University Hospital
Philadelphia, Pennsylvania |
Joint Accreditation Statement
|
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ViralEd, Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Credit Designation
Module 1: Initiating ARV Therapy:
The Postgraduate Institute for Medicine designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this continuing
medical education activity for .50 contact hour(s)(0.05 CEUs) of the
Accreditation Council for Pharmacy Education.
Universal Activity Number: UAN JA4008162-9999-22-177-H01-P
Type of Activity: Knowledge
Module 2: Switching ARV Therapy - Stable Switch:
The Postgraduate Institute for Medicine designates this enduring material for a maximum of .50 AMA PRA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this continuing
medical education activity for .50 contact hour(s)(0.05 CEUs) of the
Accreditation Council for Pharmacy Education.
Universal Activity Number: UAN JA4008162-9999-22-178-H01-P
Type of Activity: Knowledge
Module 3: Switching ARV Therapy Due to Toxicities/Co-morbidities:
The Postgraduate Institute for Medicine designates this enduring material for a maximum of .50 AMA PRAPRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this continuing
medical education activity for .50 contact hour(s)(0.05 CEUs) of the
Accreditation Council for Pharmacy Education.
Universal Activity Number: UAN JA4008162-9999-22-179-H01-P
Type of Activity: Knowledge
Module 4: Switching ARV Therapy Due to Treatment Failure:
The Postgraduate Institute for Medicine designates this enduring material for a maximum of .50 AMA PRA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this continuing
medical education activity for .50 contact hour(s)(0.05 CEUs) of the
Accreditation Council for Pharmacy Education.
Universal Activity Number: UAN JA4008162-9999-22-180-H01-P
Type of Activity: Knowledge
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners and
others in
control of educational content to disclose all thier financial
relationships with ineligible companies. All identified conflicts of
interest (COI) are thoroughly vetted and mitigated
according to PIM policy. PIM is committed to providing its learners with
high quality accredited continuing education activities and related
materials that promote
improvements or quality in healthcare and not a specific proprietary
business interest of an ineleigible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the content of this
CME activity:
Joseph Eron, MD
- Consultant/Advisory Board: ViiV, Gilead, GSK, Merck, Janssen (relationship ended)
- Grant/Research Support: Gilead, ViiV, Janssen (relationship ended)
Richard Elion, MD
- Consultant/Advisory Board: Merck, Gilead, ViiV
- Speakers Bureau/Honoraria for Non-CME: Gilead, ViiV
- Other financial or material suport (Expert Witness): Gilead
Helena Kwakwa, MD
- Grant/Research Support: ViiV
David Koren, PharmD
- Grant/Research Support: Gilead, ViiV, Merck, Lilly
- Consultan/Advisory Board: Abbvie, Gilead, ViiV, Thera, Janssen
The PIM planners and others have nothing to disclose. The ViralEd, Inc. planners and others have nothing to disclose
Method of Participation and Request for Credit
1) Go to http://www.cmeuniversity.com/
2) Login or Create a New Account (will take less than 1 minute)
a) If you receive a message when creating a new account that "the
email you entered is already in use", please click the Forgot my
Username or Password link to have your Username and Password sent to you
via email
b) After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
3) Type in 16967 at the top of the page, "Find Post-Test/Evaluation by Course", and click enter
4) Click on the activity title when it appears
5) Choose the type of credit you desire
6) (If applicable) Complete the Post-test with a passing score of 75% or better
7) Complete the online Evaluation
8) Receive an immediate CE Certificate to download and/or print for your files
9) For Pharmacists: Upon successfully completing the post-test with a
score of 75% or better and the activity evaluation form, transcript
information will be sent to the NABP CPE Monitor Service.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs
|